ADULT ACUTE LYMPHOBLASTIC LEUKEMIA IN COMPLETE REMISSION
Clinical trials for ADULT ACUTE LYMPHOBLASTIC LEUKEMIA IN COMPLETE REMISSION explained in plain language.
Never miss a new study
Get alerted when new ADULT ACUTE LYMPHOBLASTIC LEUKEMIA IN COMPLETE REMISSION trials appear
Sign up with your email to follow new studies for ADULT ACUTE LYMPHOBLASTIC LEUKEMIA IN COMPLETE REMISSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo shows promise against tough leukemia
Disease control OngoingThis study tests a powerful chemotherapy regimen (Hyper-CVAD) combined with the targeted drug ponatinib in people with a specific type of acute lymphoblastic leukemia (ALL) that has a genetic change called the Philadelphia chromosome. The goal is to see if this combination can be…
Matched conditions: ADULT ACUTE LYMPHOBLASTIC LEUKEMIA IN COMPLETE REMISSION
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:23 UTC
-
New drug combo aims to tame stem cell Transplant's worst side effect
Disease control OngoingThis study tests whether adding a drug called cyclophosphamide after a stem cell transplant can reduce the risk of graft-versus-host disease (GVHD), a serious complication where donor cells attack the patient's body. The trial includes 35 adults with various blood cancers who are…
Matched conditions: ADULT ACUTE LYMPHOBLASTIC LEUKEMIA IN COMPLETE REMISSION
Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 26, 2026 08:22 UTC